DMMA warns regulatory burden threatening Gujarat’s pharma MSMEs
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets are indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least 25 kg
Ultra-high purity surfactant for biologics and parenteral drug formulations
Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab
The positive opinion is based on results from KOMET, the largest and only placebo-controlled, double-blind global Phase III trial in this patient population
The facility has been classified as Voluntary Action Indicated
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Corning and SGD Pharma formed JV in June 2023 to expand pharmaceutical manufacturing in India
Relonchem receives marketing authorization for Moxonidine tablets
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Subscribe To Our Newsletter & Stay Updated